The HIV-1 trimer vaccine induced mild-to-moderate adverse effects, exhibiting a similar safety profile to other approved mRNA vaccines.

Strong execution and progress across pipeline with multiple key data read outs expected in 2025Late breaking oral presentation on Phase 2 CSU program at EAACI 2025 in JunePhase 3 barzolvolimab CSU ...

Researchers conducted a cross-sectional study at six tertiary photobiology units in the United Kingdom between October 2019 ...

The "Chronic Spontaneous Urticaria Market - A Global and Regional Analysis: Focus on Country and Regional Analysis - Analysis and Forecast, 2025-2035" report has been added to ResearchAndMarkets.com's ...

Patients with moderate to severe chronic spontaneous urticaria that were antihistamine-resistant to omalizumab experienced ...

ARS Pharmaceuticals has a recently launched needle-free epinephrine product for allergic reactions, neffy. See why I rate ...

CHRONIC spontaneous urticaria (CSU) is a distressing inflammatory skin condition characterised by the recurrent appearance of ...

In this phase 1 randomized controlled trial, urticaria was reported in several participants who received a messenger RNA ...

A safety analysis of mRNA vaccination in a phase 1, randomized, open-label clinical trial evaluated the safety and ...

Approval granted for adults and children 12 years and older who remain symptomatic despite antihistamine treatment.

With spring underway, the likelihood of getting a tick-borne illness is elevated, according to Mayo Clinic. One that clinicians should be on the watch for is alpha-gal syndrome, a food allergy ...